Quantum-Si [QSI] vs Abbott Laboratories [ABT] Detailed Stock Comparison
Quantum-Si
NASDAQ
Loading...
Abbott Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Quantum-Si wins in 8 metrics, Abbott Laboratories wins in 10 metrics, with 0 ties. Abbott Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Quantum-Si | Abbott Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.61 | 16.48 | Quantum-Si |
| Price-to-Book Ratio | 0.95 | 4.52 | Quantum-Si |
| Debt-to-Equity Ratio | 5.04 | 26.50 | Quantum-Si |
| PEG Ratio | -1.44 | 0.45 | Quantum-Si |
| EV/EBITDA | -0.26 | 20.56 | Quantum-Si |
| Profit Margin (TTM) | 52.32% | 32.43% | Quantum-Si |
| Operating Margin (TTM) | -4,527.58% | 19.73% | Abbott Laboratories |
| EBITDA Margin (TTM) | N/A | 19.73% | N/A |
| Return on Equity | -46.87% | 30.93% | Abbott Laboratories |
| Return on Assets (TTM) | -27.01% | 6.62% | Abbott Laboratories |
| Free Cash Flow (TTM) | $-92.44M | $6.35B | Abbott Laboratories |
| Dividend Yield | N/A | 1.28% | N/A |
| 1-Year Return | 22.11% | 16.01% | Quantum-Si |
| Price-to-Sales Ratio (TTM) | 67.66 | 5.30 | Abbott Laboratories |
| Enterprise Value | $27.78M | $235.48B | Abbott Laboratories |
| EV/Revenue Ratio | 8.14 | 5.46 | Abbott Laboratories |
| Gross Profit Margin (TTM) | 59.39% | 56.44% | Quantum-Si |
| Revenue per Share (TTM) | $0 | $25 | Abbott Laboratories |
| Earnings per Share (Diluted) | $-0.67 | $7.97 | Abbott Laboratories |
| Beta (Stock Volatility) | 2.89 | 0.71 | Abbott Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Quantum-Si vs Abbott Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Quantum-Si | -1.29% | 16.00% | -35.20% | -39.58% | -14.07% | -72.96% |
| Abbott Laboratories | -0.08% | -0.74% | 4.04% | -1.11% | -3.25% | 15.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Quantum-Si | 22.11% | -62.09% | -88.26% | -88.26% | -88.26% | -88.26% |
| Abbott Laboratories | 16.01% | 28.20% | 26.16% | 205.11% | 439.67% | 510.36% |
Performance & Financial Health Analysis: Quantum-Si vs Abbott Laboratories
| Metric | QSI | ABT |
|---|---|---|
| Market Information | ||
| Market Cap | $230.84M | $228.57B |
| Market Cap Category | Micro cap | Mega cap |
| 10 Day Avg. Volume | 8,216,800 | 4,793,458 |
| 90 Day Avg. Volume | 7,303,243 | 6,842,669 |
| Last Close | $1.14 | $131.35 |
| 52 Week Range | $0.61 - $5.77 | $110.86 - $141.23 |
| % from 52W High | -80.16% | -7.00% |
| All-Time High | $25.00 (Feb 15, 2021) | $142.60 (Dec 27, 2021) |
| % from All-Time High | -95.44% | -7.89% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | 0.07% |
| Quarterly Earnings Growth | N/A | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 0.52% | 0.32% |
| Operating Margin (TTM) | -45.28% | 0.20% |
| Return on Equity (TTM) | -0.47% | 0.31% |
| Debt to Equity (MRQ) | 5.04 | 26.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.20 | $29.05 |
| Cash per Share (MRQ) | $1.06 | $4.18 |
| Operating Cash Flow (TTM) | $-92,385,000 | $9.04B |
| Levered Free Cash Flow (TTM) | $-49,772,624 | $5.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.28% |
| Last 12-Month Dividend | N/A | $1.69 |
Valuation & Enterprise Metrics Analysis: Quantum-Si vs Abbott Laboratories
| Metric | QSI | ABT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.61 | 16.48 |
| Forward P/E | -1.44 | 25.45 |
| PEG Ratio | -1.44 | 0.45 |
| Price to Sales (TTM) | 67.66 | 5.30 |
| Price to Book (MRQ) | 0.95 | 4.52 |
| Market Capitalization | ||
| Market Capitalization | $230.84M | $228.57B |
| Enterprise Value | $27.78M | $235.48B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.14 | 5.46 |
| Enterprise to EBITDA | -0.26 | 20.56 |
| Risk & Other Metrics | ||
| Beta | 2.89 | 0.71 |
| Book Value per Share (MRQ) | $1.20 | $29.05 |
Financial Statements Comparison: Quantum-Si vs Abbott Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | QSI | ABT |
|---|---|---|
| Revenue/Sales | $842,000 | $10.36B |
| Cost of Goods Sold | $356,000 | $4.47B |
| Gross Profit | $486,000 | $5.89B |
| Research & Development | $13.72M | $716.00M |
| Operating Income (EBIT) | $-25.11M | $1.69B |
| EBITDA | $-30.14M | $2.66B |
| Pre-Tax Income | $-19.18M | $1.78B |
| Income Tax | $11,000 | $453.00M |
| Net Income (Profit) | $-19.19M | $1.33B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | QSI | ABT |
|---|---|---|
| Cash & Equivalents | $37.29M | $6.53B |
| Total Current Assets | $241.81M | $23.15B |
| Total Current Liabilities | $12.57M | $13.00B |
| Long-Term Debt | $10.12M | $12.74B |
| Total Shareholders Equity | $246.92M | $49.06B |
| Retained Earnings | $-615.83M | $47.72B |
| Property, Plant & Equipment | $26.36M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | QSI | ABT |
|---|---|---|
| Operating Cash Flow | $-16.98M | $1.42B |
| Capital Expenditures | $-1.31M | $-484.00M |
| Free Cash Flow | $-27.46M | $933.00M |
| Debt Repayment | N/A | $-1.00B |
| Common Stock Repurchase | N/A | $-280.00M |
Short Interest & Institutional Ownership Analysis
| Metric | QSI | ABT |
|---|---|---|
| Shares Short | 21.81M | 17.11M |
| Short Ratio | 2.79 | 2.18 |
| Short % of Float | 0.13% | 0.01% |
| Average Daily Volume (10 Day) | 8,216,800 | 4,793,458 |
| Average Daily Volume (90 Day) | 7,303,243 | 6,842,669 |
| Shares Outstanding | 166.89M | 1.73B |
| Float Shares | 165.75M | 1.73B |
| % Held by Insiders | 0.12% | 0.01% |
| % Held by Institutions | 0.32% | 0.81% |
Dividend Analysis & Yield Comparison: Quantum-Si vs Abbott Laboratories
| Metric | QSI | ABT |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.69 |
| Last 12-Month Dividend Yield | N/A | 1.28% |
| 3-Year Avg Annual Dividend | N/A | $1.92 |
| 3-Year Avg Dividend Yield | N/A | 0.49% |
| 3-Year Total Dividends | N/A | $5.77 |
| Ex-Dividend Date | N/A | Jan 15, 2025 |